Search

Copyright of World Water Policy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The box tree moth poses a threat to the Anatolian boxwood (Buxus sempervirens) which has significant economic and ecological value in Türkiye. This study aimed to determine the economic feasibility of pest control with solar-powered light-pheromone (SPLP) traps against the box tree moth in the Ağva Forest District of Şile Forest Enterprise, which is the only region in Türkiye with a management plan for boxwood shoot utilization. For the economic feasibility analysis, approaches including net present value, benefit-cost ratio, and the comparison of discounted finite cost of control with the capital value of infinite revenues were used. Considering the revenues of the Şile Forest Enterprise from the sale of the boxwood shoots in a finite period, it was found that pest control with the SPLP traps is not economical, producing a benefit-cost ratio of 0.371 with a net present value of -229,647.10 TL. In addition to the revenue of the enterprise, after taking into account regional income losses, water production value, and the benefits of other non-market ecosystem services provided by boxwood areas, the benefit-cost ratio increased to 2.688, and pest control became economically feasible. It was determined that the capital value of the infinite annual revenues from boxwood shoots was greater than the present value of the pest control costs against the box tree moth in a period. [ABSTRACT FROM AUTHOR]

Keywords: cost-benefit analysis; cost-effectiveness; detection dog; eradication; invasive species; scent; threatened species; análisis de costo-beneficio; erradicación; especie amenazada; especie invasora; olfato; perro detector; rentabilidad Perhaps the most useful of the studies that reported costs were those that compared detection dog costs to alternative techniques and provided a full itemization of the expense categories. A number of studies purchased dogs either from shelters or from professional sources for the purpose of the study; dogs sometimes worked with multiple handlers. Eleven studies compared dogs with human surveyors, although 3 of these simply made limited comments without providing supporting evidence (e.g., that dogs can reduce time and cost compared with human-based surveys [Nielsen et al. [54]], dogs are 5 times faster than humans [Bennett [7]], and dogs are 19 times faster than humans [Cristescu et al. [16]]). [Extracted from the article]

Copyright of Lecturas de Economia is the property of Universidad de Antioquia, Facultad de Ciencias Economicas and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Abstract: Worldwide, invasive species are a leading driver of environmental change across terrestrial, marine, and freshwater environments and cost billions of dollars annually in ecological damages and economic losses. Resources limit invasive‐species control, and planning processes are needed to identify cost‐effective solutions. Thus, studies are increasingly considering spatially variable natural and socioeconomic assets (e.g., species persistence, recreational fishing) when planning the allocation of actions for invasive‐species management. There is a need to improve understanding of how such assets are considered in invasive‐species management. We reviewed over 1600 studies focused on management of invasive species, including flora and fauna. Eighty‐four of these studies were included in our final analysis because they focused on the prioritization of actions for invasive species management. Forty‐five percent (n = 38) of these studies were based on spatial optimization methods, and 35% (n = 13) accounted for spatially variable assets. Across all 84 optimization studies considered, 27% (n = 23) explicitly accounted for spatially variable assets. Based on our findings, we further explored the potential costs and benefits to invasive species management when spatially variable assets are explicitly considered or not. To include spatially variable assets in decision‐making processes that guide invasive‐species management there is a need to quantify environmental responses to invasive species and to enhance understanding of potential impacts of invasive species on different natural or socioeconomic assets. We suggest these gaps could be filled by systematic reviews, quantifying invasive species impacts on native species at different periods, and broadening sources and enhancing sharing of knowledge. [ABSTRACT FROM AUTHOR]

The current conditions of the markets and favorable policies, as well as the progress of science and communications, are promoting further development and diffusion of agricultural innovations, which have effects on different areas of agrarian development. The objective of this paper is to present a review of characteristics of agricultural innovations and their diffusion, adoption and impacts, as well as an update of the types and methods of assessment. Agricultural innovations are not only new or improved products, they are also models and systems, and should have a positive social effect. Innovation areas in developing countries are more concentrated on production and distribution, whereas developed countries concentrate on offering inputs. Investments from the private sector in agricultural innovations are growing faster than those from the public sector. The adoption of innovations is medium-term, and usually less than 100%. The impact of innovations includes intermediate areas, such as institutional, political, scientific and productive areas. The economic efficiency of the investment in innovations is the most often mentioned purpose of impact assessments in the literature. The efficiency analysis (ex-post) and its surplus approach is still the most used method for assessing impact of agricultural innovations. Nevertheless, other goals are becoming more important, such as food security, environmental protection and poverty reduction. Livelihood, comprehensive and multidimensional approaches go beyond the economic approach. Moreover, specific models with advantages of prognosis and improved precision are replacing or complementing the classic socio-economic approach

Conservation decision makers commonly use project-scoring metrics that are inconsistent with theory on optimal ranking of projects. As a result, there may often be a loss of environmental benefits. We estimated the magnitudes of these losses for various metrics that deviate from theory in ways that are common in practice. These metrics included cases where relevant variables were omitted from the benefits metric, project costs were omitted, and benefits were calculated using a faulty functional form. We estimated distributions of parameters from 129 environmental projects from Australia, New Zealand, and Italy for which detailed analyses had been completed previously. The cost of using poor prioritization metrics (in terms of lost environmental values) was often high-up to 80% in the scenarios we examined. The cost in percentage terms was greater when the budget was smaller. The most costly errors were omitting information about environmental values (up to 31% loss of environmental values), omitting project costs (up to 35% loss), omitting the effectiveness of management actions (up to 9% loss), and using a weighted-additive decision metric for variables that should be multiplied (up to 23% loss). The latter 3 are errors that occur commonly in real-world decision metrics, in combination often reducing potential benefits from conservation investments by 30-50%. Uncertainty about parameter values also reduced the benefits from investments in conservation projects but often not by as much as faulty prioritization metrics. [ABSTRACT FROM AUTHOR]

Emergency medical care is not a luxury for rich countries or rich individuals in poor countries. This paper makes the point that emergency care can make an important contribution to reducing avoidable death and disability in low- and middle-income countries. But emergency care needs to be planned well and supported at all levels - at the national, provincial and community levels - and take into account the entire spectrum of care, from the occurrence of an acute medical event in the community to the provision of appropriate care at the hospital. The mix of personnel, materials, and health-system infrastructure can be tailored to optimize the provision of emergency care in settings with different levels of resource availability. The misconception that emergency care cannot be cost effective in low-income settings is demonstrably inaccurate. Emergencies occur everywhere, and each day they consume resources regardless of whether there are systems capable of achieving good outcomes. With better planning, the ongoing costs of emergency care can result in better outcomes and better cost-effectiveness. Every country and community can and should provide emergency care regardless of their place in the ratings of developmental indices. We make the case for universal access to emergency care and lay out a research agenda to fill the gaps in knowledge in emergency care.

OBJETIVO: Presentar una estimación de los costos y resultados de salud que podrían obtenerse en México con la introducción de un programa de vacunación contra influenza en los adultos de 65 años de edad y más. MATERIAL Y MÉTODOS: Entre junio y octubre de 2004, en Cuernavaca, Morelos, México, se elaboró un modelo para estimar el número de años de vida que se pierden por problemas de salud ocasionados por la influenza y el porcentaje de los que podrían salvarse mediante la vacunación por influenza en adultos de 65 años de edad y más, así como el costo asociado a la atención de casos de influenza y el costo potencial de la vacunación, para obtener el costo neto por año de vida salvado. RESULTADOS: Utilizando dos escenarios de efectividad de la vacuna, se estimó un total de entre 7 454 y 11 169 años de vida que podrían salvarse mediante la vacunación de todos los adultos mayores en México a un costo de entre 13 301 y 21 037 pesos por año. DISCUSIÓN: Si bien no se comparó con otros usos alternativos de los recursos, la intervención evaluada tiene un costo por año de vida ganado significativamente menor al producto interno bruto per cápita de México, lo que sugiere que es costo efectivo llevar a cabo la vacunación contra influenza en adultos de 65 años de edad en México.OBJECTIVE: To estimate costs and health outcomes that could be attained by an influenza vaccination program in adults 65 years of age and older in Mexico. MATERIAL AND METHODS: Between June and October 2004, a model was constructed to estimate the number of life years lost due to influenza and the fraction that could be prevented by vaccination among adults 65 years of age and older. The model also allowed the estimation of the net cost of a vaccination program, including both the cost of delivering the vaccine and savings from prevented infections and their treatment costs. RESULTS: Using two scenarios of vaccine effectiveness, between 7 454 and 11 169 life years could saved by the vaccine if given to all adults 65 years and older in Mexico, with a net cost per life year saved between 13 301 and 21 037 Mexican pesos (about $1 210 and $1 910 US dollars). DISCUSSION: Influenza vaccination among the elderly in Mexico would result in savings per life year saved well below the Mexican gross domestic product (GDP) per capita, suggesting, even without examining alternative uses for these resources, that this is a cost effective intervention in Mexico and probably also in other middle-income developing countries.

Estimating the economic value to societies of health research is a complex but essential step in establishing and justifying appropriate levels of investment in research. The practical difficulties encountered include: identifying and valuing the relevant research inputs (when many pieces of research may contribute to a clinical advance); accurately ascribing the impact of the research; and appropriately valuing the attributed economic impact. In this review, relevant studies identified from the literature were grouped into four categories on the basis of the methods used to value the benefits of research. The first category consists of studies that value the direct cost savings that could arise from research leading either to new, less-costly treatments or to developments such as vaccines that reduce the number of patients needing treatment. The second category comprises studies that consider the value to the economy of a healthy workforce. According to this "human capital" approach, indirect cost savings arise when better health leads to the avoidance of lost production. The third category includes studies that examine gains to the economy in terms of product development, consequent employment and sales. The studies placed in the fourth category measure the intrinsic value to society of the health gain, by placing a monetary value on a life. The review did not identify any consistency of methodology, but the fourth approach has most promise as a measure of social value. Many of the studies reviewed come from industrialized nations and a proposal is made by the present reviewers for an international initiative, covering developed and developing countries, to undertake further methodological analysis and testing.

A disease is controlled if, by means of a public policy, the circulation of an infectious agent is restricted below the level that would be sustained by individuals acting independently to control the disease. A disease is eliminated if it is controlled sufficiently to prevent an epidemic from occurring in a given geographical area. Control and elimination are achieved locally, but a disease can only be eradicated if it is eliminated everywhere. Eradication is plainly a more demanding goal, but it has two advantages over control. First, the economics of eradication can be very favourable when eradication not only reduces infections but also avoids the need for vaccinations in future. Indeed, when eradication is feasible, it will either pay to control it to a fairly low level or to eradicate it. This suggests that, from an economics perspective, diseases that are eliminated in high-income countries are prime candidates for future eradication efforts. Second, the incentives for countries to participate in an eradication initiative can be strong; indeed they can be even stronger than an international control programme. Moreover, high-income countries typically benefit so much that they will be willing to finance elimination in developing countries. Full financing of an eradication effort by nation-states is not always guaranteed, but it can be facilitated by a variety of means. Hence, from the perspective of economics and international relations, eradication has a number of advantages over control. The implications for smallpox and polio eradication programmes are discussed.

Evidence-based reviews of published literature can be subject to several biases. Grey literature, however, can be of poor quality and expensive to access. Effective search strategies also vary by topic and are rarely known in advance. This paper complements a systematic review of the published literature on the costs and effects of expanding immunization services in developing countries. The quality of data on the effectiveness and cost-effectiveness of strategies to increase immunization coverage is shown to be similar across literatures, but the quality of information on costing is much lower in the grey literature. After excluding poorer quality studies from this review we found the quantity of available evidence almost doubled, particularly for more complex health-system interventions and cost or cost-effectiveness analyses. Interventions in the grey literature are more up to date and cover a different geographical spread. Consequently the conclusions of the published and grey literatures differ, although the number of papers is still too low to account for differences across types of interventions. We recommend that in future researchers consider using non-English keywords in their searches.

OBJECTIVE: This study aimed to estimate the incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in the Loralai district of Pakistan. The supplemental immunization activities were carried out in two phases during 2001-03. METHODS: A state-transition model was used to estimate the effect of routine vaccination with tetanus toxoid as well as vaccination with tetanus toxoid during supplementary immunization activities. The model follows each woman in the target population from birth until the end of her childbearing years, using age-specific fertility data and vaccination history to determine the number of births at risk for neonatal tetanus. Recently published data on the incidence of neonatal tetanus from Loralai was used to determine the number of cases occurring with and without supplementary immunization activities. Data on the costs of the activities were collected from the UNICEF office in Balochistan and from the Provincial Health Department. FINDINGS: Using base-case assumptions we estimated that the supplementary immunization activities would prevent 280 cases of neonatal tetanus and 224 deaths from neonatal tetanus between 2001 and 2034. Implementation of the supplementary activities was relatively inexpensive. The cost per tetanus toxoid dose delivered was US$ 0.40. In the base-case analysis the cost per death averted was US$ 117.00 (95% confidence interval (CI) = US$ 78-205) and the cost per disability-adjusted life year (DALY) averted was US$ 3.61 (95% CI = US$ 2.43-6.39). CONCLUSION: Compared with similar analyses of other interventions, the cost per DALY averted is a favourable cost-effectiveness ratio. However, if routine diphtheria-tetanus-pertussis vaccination coverage in the Loralai district had been higher (at a coverage rate of about 80%) the cost-effectiveness of the intervention would have been even more favourable, at US$ 2.65 per DALY averted.

Copyright of Revista Docencia Universitaria is the property of Universidad Industrial de Santander and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Resumen La organización del sistema de salud en Cuba, que tiene como base la Atención Primaria de Salud, tendrá necesariamente que abordar el estudio y la implementación de la evaluación económica. La presente comunicación permite un acercamiento a conceptos relacionados con la Economía de la Salud. Se abordan las definiciones de economía, evaluación económica, eficiencia económica, costo, beneficio y costo de oportunidad, en el contexto de un ejemplo hipotético de un problema de salud en la atención primaria. Se concluyó que el uso de la evaluación económica proporciona un marco de análisis más integral de los problemas de salud.Summary The organization of the health system in Cuba that is based on Primary Health Care will have to undertake the study and implementation of economic evaluation. The present communication allows to deal with concepts related to Health Economics. Definitions of economy, economic evaluation, economic efficiency, cost, and cost-benefit of opportunity are approached in the context of a hypothetical example of a health problem in primary care. It was concluded that the use of economic evaluation offers a more comprehensive framework for analyzing health problems.

Many retirees from the United States of America have limited health insurance coverage while living in Mexico. Medicare and Medicaid benefits are not portable to other countries and Medigap (private insurance that supplements Medicare) is very limited. This causes economic and medical hardships and serves as a barrier to retirement to Mexico. Increasing numbers of U.S. retirees will be interested in moving to Mexico in the future because of the climate, the culture, and the lower cost of living. The numbers are increasing as a result of several factors such as aging "baby boomers" and the rapidly growing Mexican-origin population in the U.S.A. who are citizens or permanent residents but would like to return to their communities of origin after working in the U.S.A. There are several policy initiatives that could provide opportunities for improving health insurance coverage for these retirees that could be cost-effective. The full version of this paper is available too at: http://www.insp.mx/salud/index.htmlMuchos jubilados estadunidenses cuentan con una cobertura de seguro médico restringida mientras viven en México. Los beneficios de Medicare y Medicaid no son transferibles a otros países, y el Medigap (el seguro privado que complementa a Medicare) es muy limitado. Esto genera privaciones económicas y médicas y es una barrera para el retiro en México. Un número creciente de jubilados estadunidenses estaría interesado en mudarse a México en el futuro, debido al clima, la cultura y el costo más bajo de la vida. Este número creciente es resultado de varios factores: el envejecimiento de los baby boomers y la creciente población de origen mexicano con ciudadanía estadunidense o con residencia permanente, a la que le gustaría regresar a su comunidad de origen después de haber trabajado en Estados Unidos de América. En este trabajo se presentan diversas iniciativas que podrían ofrecer oportunidades para mejorar la cobertura de seguro médico para los retirados y que, además, podrían ser costo-efectivas. El texto completo de este artículo también está disponible en: http://www.insp.mx/salud/index.html

Se realiza un estudio descriptivo de corte transversal de costo-eficiencia en el policlínico "Turcios Lima" en Ciudad de La Habana, que correlaciona los gastos y resultados de salud alcanzados en el período de un año. Se analiza el presupuesto y los costos unitarios, obtenidos de la aplicación del sistema aprobado para ese fin por el Ministerio de Salud Pública. Se muestra el comportamiento de un grupo de indicadores de salud seleccionados, que reflejan el grado de eficacia. Se establece una relación entre ambos aspectos, concluyendo que existen reservas de eficiencia económica sin explotar, basándonos para ello en los resultados siguientes: el salario representa el 75 % de los gastos, los altos costos por consulta del Plan Familia son de $ 3,65, en Interconsultas de $ 11,09, en Atención Médica Especializada de $ 10,59 y en Psicología de $ 10,50. Los consultorios en centros de trabajo y educacionales son caros, al igual que los medios diagnósticos. Se recomienda la evaluación sistemática en las reuniones del GBT de los resultados de costosA cross-sectional descriptive study of cost-efficiency was conducted at "Turcios Lima" Polyclinic in Havana City to correlate the health expenditures and the results attained during a year. The budget as well as the unitary costs resulting from the application of the system approved by the Ministry of Public Health are analyzed. The behavior of a group of selected health indicators reflecting the degree of efficiency is shown. A relationship between both aspects is established and it is concluded that there are reserves of economic efficiency that have not been exploted yet based on the following results: the salary accounts for 75% of the expenditures, the high costs by consultation of the Family Physician Plan are $3,65; in Interconsultations, $11,09; in Specialized Medical Attention, $10,59; and in Psychology, $10,50. The physcian?s offices in working and educational centers are expensive, as a well as the diagnostic tools. It is recommended the systematic evaluation of the results of the costs in the meetings of the Working Basic Group

OBJETIVO: Analisó el costo-efectividad en intervenciones para pacientes con insuficiencia renal crónica terminal (IRCT) en términos de los costos económicos de cada intervención, los años de vida ganados y la calidad de vida que generan tres alternativas comparables y mutuamente excluyentes: diálisis peritoneal contínua ambulatoria (DPCA), la hemodiálisis (HD) y el trasplante renal (TR). MÉTODO: El diseño del estudio fue de tipo longitudinal. Los costos de cada intervención se determinaron mediante la técnica de manejo de caso promedio. Las medidas para evaluar los criterios de efectividad elegidos fueron la probabilidad de sobrevida y el Año de Vida Ajustado por Calidad (QALY, Quality Adjusted Life Year) medido por el Indice de Rosser. RSULTADOS: Los costos de manejo anual de caso fueron: diálisis peritoneal $5,643.07, hemodiálisis $9,631.60 y trasplante $3,021.63. En cuanto a la efectividad, la sobrevida del injerto de trasplante renal resultó de 89,9% y 79,6% a uno y tres años respectivamente, mientras que los pacientes sometidos a DPCA tienen una sobrevida de 86,2% y 66,9% a un año y a tres años respectivamente. En cuanto a los QALY's, los resultados para cada intervención fueron: DPCA 0,879; HD 0,864; y para el TR 0,978. CONCLUSIÓN: La intervención más costo-efectiva resultó el trasplante renal con un coeficiente de 3,088.69, seguido de la DPCA y la hemodiálisis, cuyos coeficientes fueron de 6,416.95 y 11,147.68 respectivamente. Por lo tanto se recomienda promover y utilizar el trasplante renal como la intervención más costo-efectiva para pacientes con IRCT.

Se realizó una investigación descriptiva para estimar los costos y beneficios del ingreso en el hogar. El análisis económico se realizó desde una perspectiva social. Los grupos poblacionales donde más se utilizó la técnica fueron las gestantes y los menores de 1 año. Las enfermedades respiratorias altas y la gestación a término fueron los que más incidencia tuvieron; los medicamentos más utilizados estuvieron en correspondencia con las enfermedades y su disponibilidad. El tiempo hospitalario no se comportó de igual forma en todos los grupos. Los gastos de bolsillo representaron el mayor porcentaje dentro de los costos directos tangibles, ocasionados en su mayoría por alimentación adicional. Los gastos del sector salud fueron superiores a los de familiares y pacientes. Los costos indirectos fueron inferiores a los directos. El estudio demostró que el 88,6% se curó, se complicó el 8,8% y falleció el 2,5%A descriptive research was conducted to estimate the costs and benefits of home admission. The economic analysis was made from a social perspective. This technique was more used among pregnant women and children under 1. Upper respiratory diseases and term gestations had the greatest incidence. The most administered drugs were in correspondence with their availability and the diseases. Hospital stay did not have the same behavior in all groups. Pocket expenses accounted for the highest percentage within the tangible direct costs mainly caused by additional food. Health sector expenditures were higher than those of relatives and patients. Indirect costs were lower than the direct ones. The study showed that 88.6 % got cured, 8.8 % presented complications and 2.5 % died

OBJETIVO: Analisó el costo-efectividad en intervenciones para pacientes con insuficiencia renal crónica terminal (IRCT) en términos de los costos económicos de cada intervención, los años de vida ganados y la calidad de vida que generan tres alternativas comparables y mutuamente excluyentes: diálisis peritoneal contínua ambulatoria (DPCA), la hemodiálisis (HD) y el trasplante renal (TR). MÉTODO: El diseño del estudio fue de tipo longitudinal. Los costos de cada intervención se determinaron mediante la técnica de manejo de caso promedio. Las medidas para evaluar los criterios de efectividad elegidos fueron la probabilidad de sobrevida y el Año de Vida Ajustado por Calidad (QALY, Quality Adjusted Life Year) medido por el Indice de Rosser. RSULTADOS: Los costos de manejo anual de caso fueron: diálisis peritoneal $5,643.07, hemodiálisis $9,631.60 y trasplante $3,021.63. En cuanto a la efectividad, la sobrevida del injerto de trasplante renal resultó de 89,9% y 79,6% a uno y tres años respectivamente, mientras que los pacientes sometidos a DPCA tienen una sobrevida de 86,2% y 66,9% a un año y a tres años respectivamente. En cuanto a los QALY's, los resultados para cada intervención fueron: DPCA 0,879; HD 0,864; y para el TR 0,978. CONCLUSIÓN: La intervención más costo-efectiva resultó el trasplante renal con un coeficiente de 3,088.69, seguido de la DPCA y la hemodiálisis, cuyos coeficientes fueron de 6,416.95 y 11,147.68 respectivamente. Por lo tanto se recomienda promover y utilizar el trasplante renal como la intervención más costo-efectiva para pacientes con IRCT.

Copyright of Revista de Salud Pública is the property of Universidad Nacional de Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ante el creciente deterioro ambiental y sus posibles consecuencias en la salud de la población resulta una prioridad indiscutible el diseño e instrumentación de políticas que controlen las actividades económicas bajo el criterio de protección a la salud humana y al ambiente mismo. Es preciso que dichas políticas consideren la factibilidad económica de las alternativas de protección existentes. Sin embargo, por la cantidad de intereses dentro del área ambiental, otros factores como el social y el político deben también ser considerados. La evaluación económica ha sido vista como un promisorio fundamento para la toma de decisiones en esta materia. Los autores analizan la capacidad de esta herramienta para organizar en forma sistemática y comparable los costos y los beneficios de alternativas para la solución de problemas ambientales. Se resumen las principales características de los estudios de costo-beneficio y costo-efectividad, las formas de evaluación económica del ambiente, y las particularidades de esta área para la aplicación de dichas técnicas de análisis. Se señalan los límites encontrados en estas herramientas para cuantificar los costos no monetarios de los riesgos ambientales y de los consecuentes daños a la salud, tales como el dolor, el sufrimiento ó la incapacidad de personas económicamente inactivas, constituyendo estos aspectos el reto metodológico de la evaluación económica en el área. Se reflexiona sobre la importancia de ampliar los insumos informativos para la toma de decisiones en materia de salud ambiental en aspectos como la distribución de los costos y los beneficios entre los distintos grupos sociales. Por último se señala tanto la creciente politización del tema ambiental, como la posibilidad técnica de manipulación de estas herramientas de análisis. Partiendo de estos elementos se señala la necesidad, por parte de los evaluadores, de ser conscientes sobre las implicaciones políticas de sus estudios, así como de la importancia de su vinculación con los tomadores de decisión con el objetivo de lograr pertinencia en el ejercicio académico.Devido à crescente deterioração ambiental e as suas possíveis conseqüências para a saúde da polulação,torna-se necessário priorizar o desenho e instrumentação de políticas que controlem as atividades econômicas, considerando a proteção à saúde humana e ao próprio ambiente. É preciso que essas políticas considerem a factibilidade econômica das alternativas de proteção existentes. Não obstante, pela quantidade de interesses na área ambiental, outros fatores como o social e o político também devem ser considerados. A avaliação econômica tem sido vista como fundamental para a tomada de decisões nessa matéria. Foi analisada a capacidade desta ferramenta para organizar de forma sistemática e comparável os custos e os benefícios de alternativas para a solução dos problemas ambientais.Foram sintetizadas as principais características dos estudos de custo-benefício e custo-efetividade,as formas de avaliação econômica do ambiente e as particularidades desta área para a aplicação dessas técnicas de análise. Foram analisados os limites encontrados nessas ferramentas para calcular os custos não monetários dos riscos ambientais e dos danos conseqüentes à saúde, como a dor, o sofrimento ou a incapacidade de pessoas economicamente inativas, sendo que estes aspectos constituem o desafio metodológico da avaliação econômica na área. Analisa-se a importância de ampliar a informação para a tomada de decisões a respeito da saúde ambiental em aspectos como a distribuição dos custos e os benefícios entre os diferentes grupos sociais.Por último,assinala-se tanto a crescente politização do tema ambiental,como a possibilidade técnica de manipulação dessas ferramentas de analise.Partindo desses elementos, destaca-se a necessidade, por parte dos avaliadores, de tomar a consciência das implicações políticas dos seus estudos,assim como da importância da sua relação com as pessoas que tomam decisões para alcançar pertinência no exercício acadêmico.Due to the increasing deterioration of the enviroment and its possible consequences for the health of the population the design and implementation of policies for the control of economic activities according to criteria for the protection of human health and the environment itself have become an unquestionable need. Such policies would incluede the economic feasibility of existing alternatives for protection. Due to the huge interests involved, however, other factors, both social and political should also be taken into consideration. Economic evaluation has been seen as a promising foundation for the decision making process in this subject. This tool's capacity systematically to organize and compare the costs and the benefits of the alternatives for the solution of enviromental problems is analysed.The main characteristics of cost-benefit and cost-effectiveness studies are summarized, as well as the possible forms of economic evalution, of the enviroment and the detailsof this field for the application of such techiniques of analysis. The limits of these tools for the quantifycation of the non-monetary costs of environmental risks and the consequent damage to health, whethea as pain,suffering or the disability of non-economic ally active persons are set out as these constitute the methodological challenge of the economic evaluation in the area. The importance of the enhancement of information input for the decision-making process relating to environmental health issues such as the distributions of costs and benefits among the different social groups is scrutinized. Lastly, the growuing political concern with environment issues is stated, as well as the techinical possibility of the manipulation of these analytical tools. On the basis of these elements,the need for evaluators to be conscious on the political implications of their studies, as well as the importance of their relationship with the decision-makers in view of the need for effective relevance to current environmental issues

Ante el creciente deterioro ambiental y sus posibles consecuencias en la salud de la población resulta una prioridad indiscutible el diseño e instrumentación de políticas que controlen las actividades económicas bajo el criterio de protección a la salud humana y al ambiente mismo. Es preciso que dichas políticas consideren la factibilidad económica de las alternativas de protección existentes. Sin embargo, por la cantidad de intereses dentro del área ambiental, otros factores como el social y el político deben también ser considerados. La evaluación económica ha sido vista como un promisorio fundamento para la toma de decisiones en esta materia. Los autores analizan la capacidad de esta herramienta para organizar en forma sistemática y comparable los costos y los beneficios de alternativas para la solución de problemas ambientales. Se resumen las principales características de los estudios de costo-beneficio y costo-efectividad, las formas de evaluación económica del ambiente, y las particularidades de esta área para la aplicación de dichas técnicas de análisis. Se señalan los límites encontrados en estas herramientas para cuantificar los costos no monetarios de los riesgos ambientales y de los consecuentes daños a la salud, tales como el dolor, el sufrimiento ó la incapacidad de personas económicamente inactivas, constituyendo estos aspectos el reto metodológico de la evaluación económica en el área. Se reflexiona sobre la importancia de ampliar los insumos informativos para la toma de decisiones en materia de salud ambiental en aspectos como la distribución de los costos y los beneficios entre los distintos grupos sociales. Por último se señala tanto la creciente politización del tema ambiental, como la posibilidad técnica de manipulación de estas herramientas de análisis. Partiendo de estos elementos se señala la necesidad, por parte de los evaluadores, de ser conscientes sobre las implicaciones políticas de sus estudios, así como de la importancia de su vinculación con los tomadores de decisión con el objetivo de lograr pertinencia en el ejercicio académico.

Measures aimed at conservation or restoration of ecosystems are often seen as net-cost projects by governments and businesses because they are based on incomplete and often faulty cost-benefit analyses. After screening over 200 studies, we examined the costs (94 studies) and benefits (225 studies) of ecosystem restoration projects that had sufficient reliable data in 9 different biomes ranging from coral reefs to tropical forests. Costs included capital investment and maintenance of the restoration project, and benefits were based on the monetary value of the total bundle of ecosystem services provided by the restored ecosystem. Assuming restoration is always imperfect and benefits attain only 75% of the maximum value of the reference systems over 20 years, we calculated the net present value at the social discount rates of 2% and 8%. We also conducted 2 threshold cum sensitivity analyses. Benefit-cost ratios ranged from about 0.05:1 (coral reefs and coastal systems, worst-case scenario) to as much as 35:1 (grasslands, best-case scenario). Our results provide only partial estimates of benefits at one point in time and reflect the lower limit of the welfare benefits of ecosystem restoration because both scarcity of and demand for ecosystem services is increasing and new benefits of natural ecosystems and biological diversity are being discovered. Nonetheless, when accounting for even the incomplete range of known benefits through the use of static estimates that fail to capture rising values, the majority of the restoration projects we analyzed provided net benefits and should be considered not only as profitable but also as high-yielding investments. Beneficios de Invertir en la Restauración de Ecosistemas [ABSTRACT FROM AUTHOR]

The adoption of fisheries closures and gear restrictions in the conservation of coral reefs may be limited by poor understanding of the economic profitability of competing economic uses of marine resources. Over the past 12 years, I evaluated the effects of gear regulation and fisheries closures on per person and per area incomes from fishing in coral reefs of Kenya. In two of my study areas, the use of small-meshed beach seines was stopped after 6 years; one of these areas was next to a fishery closure. In my third study area, fishing was unregulated. Fishing yields on per capita daily wet weight basis were 20% higher after seine-net fishing was stopped. The per person daily fishing income adjacent to the closed areas was 14 and 22% higher than the fishing income at areas with only gear restrictions before and after the seine-net restriction, respectively. Incomes differed because larger fish were captured next to the closed area and the price per weight (kilograms) increased as fish size increased and because catches adjacent to the closure contained fish species of higher market value. Per capita incomes were 41 and 135% higher for those who fished in gear-restricted areas and near-closed areas, respectively, compared with those who fished areas with no restrictions. On a per unit area basis (square kilometers), differences in fishing income among the three areas were not large because fishing effort increased as the number of restrictions decreased. Changes in catch were, however, larger and often in the opposite direction expected from changes in effort alone. For example, effort declined 21% but nominal profits per square kilometer (not accounting for inflation) increased 29% near the area with gear restrictions. Gear restrictions also reduced the cost of fishing and increased the proportion of self-employed fishers. [ABSTRACT FROM AUTHOR]

Conservation funds are grossly inadequate to address the plight of threatened species. Government and conservation organizations faced with the task of conserving threatened species desperately need simple strategies for allocating limited resources. The academic literature dedicated to systematic priority setting usually recommends ranking species on several criteria, including level of endangerment and metrics of species value such as evolutionary distinctiveness, ecological importance, and social significance. These approaches ignore 2 crucial factors: the cost of management and the likelihood that the management will succeed. These oversights will result in misallocation of scarce conservation resources and possibly unnecessary losses. We devised a project prioritization protocol (PPP) to optimize resource allocation among New Zealand's threatened-species projects, where costs, benefits (including species values), and the likelihood of management success were considered simultaneously. We compared the number of species managed and the expected benefits gained with 5 prioritization criteria: PPP with weightings based on species value; PPP with species weighted equally; management costs; species value; and threat status. We found that the rational use of cost and success information substantially increased the number of species managed, and prioritizing management projects according to species value or threat status in isolation was inefficient and resulted in fewer species managed. In addition, we found a clear trade-off between funding management of a greater number of the most cost-efficient and least risky projects and funding fewer projects to manage the species of higher value. Specifically, 11 of 32 species projects could be funded if projects were weighted by species value compared with 16 projects if projects were not weighted. This highlights the value of a transparent decision-making process, which enables a careful consideration of trade-offs. The use of PPP can substantially improve conservation outcomes for threatened species by increasing efficiency and ensuring transparency of management decisions. [ABSTRACT FROM AUTHOR]

Objective To compare the cost-effectiveness of the tuberculosis (TB) programme run by the Bangladesh Rural Advancement Committee (BRAC), which uses community health workers (CHWs), with that of the government TB programme which does not use CHWs. Methods TB control statistics and cost data for July 1996–June 1997 were collected from both government and BRAC thanas (subdistricts) in rural Bangladesh. To measure the cost per patient cured, total costs were divided by the total number of patients cured. Findings In the BRAC and government areas, respectively, a total of 186 and 185 TB patients were identified over one year, with cure rates among sputum-positive patients of 84% and 82%. However, the cost per patient cured was US$ 64 in the BRAC area compared to US$ 96 in the government area. Conclusion The government programme was 50% more expensive for similar outcomes. Although both the BRAC and government TB control programmes appeared to achieve satisfactory cure rates using DOTS (a five-point strategy), the involvement of CHWs was found to be more cost-effective in rural Bangladesh. With the same budget, the BRAC programme could cure three TB patients for every two in the government programme. [ABSTRACT FROM AUTHOR]

Se conoce que entre los pacientes con infarto agudo del miocardio se producen alteraciones humorales entre las que se encuentra la disminución del magnesio sérico, que provoca diferentes complicaciones. Se estudiaron 76 pacientes, 40 de ellos supuestamente sanos y utilizados como grupo control y 36 con diagnóstico de infarto agudo del miocardio. Se determinó la concentración de magnesio en sangre en ambos grupos, y se hallaron diferencias significativas entre ellos. Se relacionaron los valores de magnesio obtenidos con la edad, el sexo y los factores de riesgo. Se encontraron diferencias entre los grupos de edad y los factores de riesgo. Se trató a los pacientes con sulfato de magnesio, posteriormente se valoró su evolución y se observaron buenos resultados en la mayoría de los casos.It is known that among patients with acute myocardial infarction there are humoral alterations as the reduction of serum magnesium that causes different complications.76 patients were studied. 40 of them who were apparently sound were used as a control group and 36 with diagnosis of acute myocardial infarction (AMI). The concentration of magnesium in blood was determined in both groups and significant differences were found between them. The values of magnesium obtained were related to age, sex and risk factors. Differences were observed between the age groups and the risk factors. Patients were treated with magnesium sulfate. Their evolution was assessed later and good results were attained in most of the cases.

Se revisaron 98 historias clínicas de pacientes operados de hiperplasia prostática benigna en el Servicio de Urología del Hospital Clinicoquirúrgico Docente "Joaquín Albarrán; por las distintas técnicas quirúrgicas. La terapéutica antimicrobiana con kanamicina se utilizó en 41 de estos casos de forma convencional, en dosis de 10 a 15 mg/kg de peso/24 h durante 7 d y los 57 casos restantes recibieron antibioticoterapia perioperatoria con ceftriaxona, en dosis de 1 g intramuscular en el momento de la inducción anestésica y 1 g intramuscular 1 h antes de la remoción del catéter uretral. Se hizo un estudio comparativo de los resultados del uso de ambos métodos profilácticos, donde se demostró el enorme beneficio, desde el punto de vista de los costos, de la ceftriaxona perioperatoria, pues implica una mayor eficacia del medicamento con menores costos hospitalarios

Introduction: Bexsero® (4CMenB), meningococcal B vaccine, was licensed in Europe in 2013. In Spain, despite MenB being the most frequent cause of invasive meningococcal disease (IMD), Bexsero® is recommended and financed for patients at increased risk of IMD but is not financed by the NHS in the routine vaccination schedule., Objective: to evaluate the cost-utility, epidemiological impact, and total costs of the introduction of 4CMenB into the vaccination schedule to help inform vaccine policy in Spain., Method: We adapted a cost-utility analysis, a probabilistic decision-tree, to Spain. A cohort of new-born infants in 2015 was modelled with two dosages, using two different strategies: routine vaccination schedule with 4CMenB and non-vaccination. Costs were measured from a payer perspective and benefits were calculated in quality-adjusted life years (QALYs). A Monte Carlo analysis and 32 scenarios were performed to assess the robustness and the uncertainty of our results., Results: With the 3+1 dosage, routine vaccination prevented 54% of cases and deaths and an incremental cost-utility ratio (ICUR) of 351.389 €/QALY (95% confidence interval [95%CI]: 265,193-538,428) was estimated. The 2+1 dosage prevented 50% of cases and deaths, with an ICUR of 278.556 €/QALY (95%CI: 210,285-430,122)., Conclusions: Given the current incidence of invasive meningococcal disease in Spain and the information available from 4CMenB, our model shows that routine vaccination is not cost-effective at the current price. Only with a vaccine price of 1.45 € for the 3+1 schedule or 3.37 € for the 2+1 schedule could it be recommended based on efficiency criteria., (Copyright © 2019 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.)

Ante el creciente deterioro ambiental y sus posibles consecuencias en la salud de la población resulta una prioridad indiscutible el diseño e instrumentación de políticas que controlen las actividades económicas bajo el criterio de protección a la salud humana y al ambiente mismo. Es preciso que dichas políticas consideren la factibilidad económica de las alternativas de protección existentes. Sin embargo, por la cantidad de intereses dentro del área ambiental, otros factores como el social y el político deben también ser considerados. La evaluación económica ha sido vista como un promisorio fundamento para la toma de decisiones en esta materia. Los autores analizan la capacidad de esta herramienta para organizar en forma sistemática y comparable los costos y los beneficios de alternativas para la solución de problemas ambientales. Se resumen las principales características de los estudios de costo-beneficio y costo-efectividad, las formas de evaluación económica del ambiente, y las particularidades de esta área para la aplicación de dichas técnicas de análisis. Se señalan los límites encontrados en estas herramientas para cuantificar los costos no monetarios de los riesgos ambientales y de los consecuentes daños a la salud, tales como el dolor, el sufrimiento ó la incapacidad de personas económicamente inactivas, constituyendo estos aspectos el reto metodológico de la evaluación económica en el área. Se reflexiona sobre la importancia de ampliar los insumos informativos para la toma de decisiones en materia de salud ambiental en aspectos como la distribución de los costos y los beneficios entre los distintos grupos sociales. Por último se señala tanto la creciente politización del tema ambiental, como la posibilidad técnica de manipulación de estas herramientas de análisis. Partiendo de estos elementos se señala la necesidad, por parte de los evaluadores, de ser conscientes sobre las implicaciones políticas de sus estudios, así como de la importancia de su vinculación con los tomadores de decisión con el objetivo de lograr pertinencia en el ejercicio académico.

OBJETIVO: Analisó el costo-efectividad en intervenciones para pacientes con insuficiencia renal crónica terminal (IRCT) en términos de los costos económicos de cada intervención, los años de vida ganados y la calidad de vida que generan tres alternativas comparables y mutuamente excluyentes: diálisis peritoneal contínua ambulatoria (DPCA), la hemodiálisis (HD) y el trasplante renal (TR). MÉTODO: El diseño del estudio fue de tipo longitudinal. Los costos de cada intervención se determinaron mediante la técnica de manejo de caso promedio. Las medidas para evaluar los criterios de efectividad elegidos fueron la probabilidad de sobrevida y el Año de Vida Ajustado por Calidad (QALY, Quality Adjusted Life Year) medido por el Indice de Rosser. RSULTADOS: Los costos de manejo anual de caso fueron: diálisis peritoneal $5,643.07, hemodiálisis $9,631.60 y trasplante $3,021.63. En cuanto a la efectividad, la sobrevida del injerto de trasplante renal resultó de 89,9% y 79,6% a uno y tres años respectivamente, mientras que los pacientes sometidos a DPCA tienen una sobrevida de 86,2% y 66,9% a un año y a tres años respectivamente. En cuanto a los QALY's, los resultados para cada intervención fueron: DPCA 0,879; HD 0,864; y para el TR 0,978. CONCLUSIÓN: La intervención más costo-efectiva resultó el trasplante renal con un coeficiente de 3,088.69, seguido de la DPCA y la hemodiálisis, cuyos coeficientes fueron de 6,416.95 y 11,147.68 respectivamente. Por lo tanto se recomienda promover y utilizar el trasplante renal como la intervención más costo-efectiva para pacientes con IRCT.